Sefrad 500 mg/vial (IM/IV Injection)
500 mg vial: ৳ 60.18 (1 x 4: ৳ 240.72)
Medicine Details
| Category | Details |
|---|---|
| Generic | Cephradine |
| Company | Synovia pharma plc |
| Also available as |
Title
- Sefrad (Cephradine) Antibiotic
- Sefrad Suspension
- Sefrad Injection
Categories
- Antibiotics
- Prescription Medicine
- Medication for Respiratory Infections
- Medication for Urinary Tract Infections
Description
- Indicated for infections caused by sensitive Gram-positive and Gram-negative bacteria
- Semisynthetic broad spectrum bactericidal antibiotic
- Active against both gram-positive and gram-negative microorganisms
- Dosage & administration details for different age groups
- Interactions with nephrotoxic drugs, diuretics, and probenecid
- Contraindicated in patients with known or suspected hypersensitivity to cephalosporins
- Possible side effects including gastrointestinal disturbances and hypersensitivity phenomena
- Precautions for prolonged use, hypersensitivity, Coombs' testing, and urine glucose testing
- Recommendations for use in special populations such as patients with renal impairment
- Information on overdose effects
- Belongs to the therapeutic class of first generation Cephalosporins
- Storage conditions for both suspension and injection forms
Dimensions
- Varies by dosage strength and formulation
Color Options
- Varies by dosage form (e.g., suspension, injection)
Functions
- Treats upper respiratory tract infections
- Treats lower respiratory tract infections
- Treats urinary tract infections
- Treats skin and soft tissue infections
Materials
- Active ingredient: Cephradine
- Inactive ingredients: excipients present in the suspension and injection formulations
Technical Specifications
- Reconstituted suspension should be used within 7-14 days, depending on storage temperature
- Injection solutions retain potency for 2-12 hours, depending on storage conditions
Design Elements
- Variation in color for the reconstituted injection solutions
Usability Features
- Oral and injectable administration options
- Dosage adjustment for renal impairment
- Recommendation for bacteriological and clinical monitoring during urinary tract infection treatment